Uma ngabe ufunde mayelana nemithi yokwelapha yokulahlekelwa izinwele, kungenzeka ukuthi uhlangabezane nomuthi obizwa nge- saw palmetto . Kuthengwa ama-berries esitshalo seNorth America esaziwa ngokuthi i- Serenoa repens noma uSabal serrulata , kuboniswe ukukhishwa kwe-palmetto ukusiza ukunciphisa noma ukunciphisa uhlobo lokulahleka kwezinwele ezibizwa ngokuthi i-androgenic alopecia (uhlobo oluvamile lokulahlekelwa izinwele olwaziwa nangokuthi lendoda- noma ukulingwa kwesifazane-iphethini).
Ngezinye izikhathi i-palmetto ibhekwa njengokwelashwa kwemvelo kwezinye izimo zezempilo, njenge-acne, i- benign prostatic hyperplasia (BPH), i- erectile dysfunction (ED), ne- polycystic syndrome (PCOS).
Izinzuzo Zokulahlekelwa Kwezinwele
Enye inkolelo yokuthi palmetto ingase isebenze kanjani ukuthi ingaba 5-alpha-reductase, i-enzyme ehilelekile ekuguquleni kwe-hormone testosterone kuya ku-dihydrotestosterone (DHT). I-DHT ibhekwa njengesihluthulelo esiyinhloko ekutholeni nasekuthuthukeni kwe-alopecia ye-androgenic. Kuthiwa futhi ukwandisa umsebenzi we-enzyme obhekene nokusetshenziswa kwe-DHT ku-androstanediol (i-hormonone ebuthakathaka obuthakathaka).
Ukuthandwa okuningi kwe-palmetto njengendlela yokwelapha izinwele nokuhlunga kusekelwe endleleni okukholelwa ngayo ukuthi isebenza kunokuba ucwaninge. Nakuba kukhona ucwaningo oluthile lwe-laboratories olubonisa ukuthi isibalo se-palmetto sinamandla okuvimbela u-5-alpha-reductase, kukhona ukuntuleka kokuhlolwa kwemitholampilo eyenziwe kahle okubonisa ukuthi i-palmetto ingabangela izinwele ukuba zibuyiselwe noma ziyeke ukuqhuma kwezinwele.
Ucwaningo olutholakalayo lubandakanya isifundo sobulili esivulekile esashicilelwe kwi- International Journal of Immunopathology and Pharmacology ngo-2012. Emadodeni angu-100 ane-alopecia ene-orrogenic etrogenic enomzimba oyedwa, iqembu elilodwa lithatha u-320 mg we-saw palmetto nsuku zonke izinyanga ezingu-24, kanti elinye iqembu lithatha 1 mg finasteride (imithi esetshenziselwa izinwele) ngosuku ngalunye.
Abacwaningi bathola ukuthi amaphuzu okukhula kwezinwele ayephezulu eqenjini elathola i-finasteride uma liqhathaniswa neqembu le-saw palmetto, nokuthi umphumela we-palmetto wawungaphansi kwe-finasteride.
Esicwaningweni esanyatheliswa kuyi- Journal of Alternative and Complementary Medicine ngo-2002, amadoda angu-26 ane-alopecia ne-androgenic alopecia enesineke kuya emodeni athatha isengezo esine-saw palmetto ne- beta-sitosterol noma i-placebo yamaviki angama-21. Ukwelashwa okuphumelelayo ekuvakashelweni kokugcina, okuhlolwe ngabasebenzi, kubikwa ukuthi kungamaphesenti angu-60 eqenjini le-saw palmetto kuqhathaniswa namaphesenti angu-11 eqenjini le-placebo. Imiphumela emibi yayimnene futhi ihamba isikhathi eside.
Imiphumela Ezingenakwenzeka
Njengamanye ama-supplements we-herbal, okuncane kuyaziwa ngemiphumela emibi yokusetshenziswa kwesikhathi eside noma ukulinganisa okuphezulu kwe-saw palmetto. Imiphumela emibi ngokuvamile ilula. Ubuhlungu besisu, ukuqotshwa, isifo sohudo, isicanucanu, nokuhlanza kubikiwe. Amanye amadoda abikile ukungasebenzi komzimba.
Kukhona ukukhathazeka okubonile ukuthi palmetto ingabangela isibindi, pancreatic, noma izinkinga zenhliziyo kwabanye abantu. Kube khona imibiko yokulimala kwesibindi nokuphazamiseka kubantu abathatha i-saw palmetto, nokho, akwanele ulwazi olwanele ukwazi ukuthi ukubona i-palmetto yimbangela yangempela yokuphendula okubi.
Nakuba kungakaze kuboniswe kahle kubantu, ukubona i-palmetto ingase ithonye amazinga ama-hormone ocansi njengo-estrogen ne-testosterone. Kuze kube yilapho sisazi kabanzi, abantu abanezimo ezibucayi, ezifana nesifo somdlavuza webele, kufanele bakugweme. Futhi, ukubona i-palmetto kungenzeka ukuthi iphazamise ukukhulelwa komlomo kanye nokwelashwa kwe-hormone futhi ingasebenza ngendlela efanayo nemithi ye-finasteride.
Izingane nabesifazane abakhulelwe noma abahlengikazi akufanele bathathe i-saw palmetto.
Ukubheka i-palmetto kunganciphisa igazi. Abantu abanenkinga yokuphaphazeka noma abathwala imithi ye-anticoagulant noma antiplatelet noma izithako, njenge-warfarin (i-Coumadin®), i-aspirin noma i-clopidogrel (i-Plavix®), kufanele igweme ukuthatha i-saw palmetto ngaphandle kokuphathwa kwezokwelapha.
Kumelwe futhi kugwenywe okungenani amasonto amabili ngaphambi kokuhlinzwa.
Kubalulekile ukukhumbula ukuthi ama-supplements awazange ahlolwe ukuphepha futhi ahlulekile ukulawulwa. Qiniseka ukuthi ufunda ngokusebenzisa izithako ngokuphepha .
Ukusebenzisa i-Saw Palmetto
Ukulahlekelwa izinwele zakho kungabangela ukucindezeleka. Nakuba kungase kube isilingo ukuqala ukusebenzisa i-saw palmetto, uma ucabangela ukuyisebenzisa, qiniseka ukuthi uthintane nomhlinzeki wakho wezempilo ukuze akhulume ukuthi kufanelekile yini. Iziningi zokwelapha izinwele zidinga ukusetshenziselwa njalo, futhi kubalulekile ukucabangela ukungabi khona kobufakazi noma ulwazi lokuphepha (ikakhulukazi nokusetshenziswa kwesikhathi eside).
Imithombo:
> Prager N, Bickett K, isiFulentshi N, uMarcovici G. Isivivinyo esilawulwa ngokungahleliwe, esiphindwe kabili-blindbo, ukucacisa ukusebenza kahle kwama-inhibitors asetshenziswe nge-5-alpha-reductase ekwelapheni i-androgenetic alopecia. J Altern Supplement Med. (2002) 8.2: 143-152.
> Rossi A, Mari E, Scarno M, et al. Ukuphumelela okufanisayo kwe-finasteride no-Serenoa kubuyela e-male androgenetic alopecia: isifundo seminyaka emibili. I-Int J Immunopathol Pharmacol. 2012 Oct-Dec; 25 (4): 1167-73.
U-Ulbricht C, u-Basch E, u-Bent S, u-Boon H, u-Corrado M, u-Foppa I, u-Hashmi S, u-Hammerness P, u-Kingsbury E, u-Smith M, u-Szapary P, u-Vora M, u-Weissner W. Ukubukezwa okuhlelekile kwesistimu ye-saw palmetto yi-Natural Ukusebenzisana okujwayelekile kwezokucwaninga. I-J Soc Integr Oncol. (2006) 4.4: 170-186.
> Wessagowit V, Tangjaturonrusamee C, Kootiratrakarn T, Bunnag T, Pimonrat T, Muangdang N, Filei P. Ukwelashwa kwe-alogieca e-androgenetic enezinhlobonhlobo eziqukethe i-Serenoa repens ukukhipha. I-Australas J Dermatol. 2016 Aug; 57 (3): e76-82.
U-TJ, u-Ishani A, u-Stark G, iMacDonald R, u-Lau J, uMelrow C. Bawubona ama-palmetto okukhipha ukwelashwa kwe-benign prostatic hyperplasia: ukubuyekezwa okuhlelekile. I-JAMA (1998) 280.18: 1604-1609.
Ukuziphendulela: Ulwazi oluqukethwe kule sayithi luhloswe ngezinjongo zemfundo kuphela futhi aluthathi iseluleko, ukuxilongwa noma ukwelashwa ngudokotela olayisensi. Akuhloselwe ukumboza zonke izinyathelo zokuqapha, ukusebenzisana kwezidakamizwa, izimo noma imiphumela emibi. Kufanele ufune ukunakekelwa okusheshayo kwezokwelapha kunoma yiziphi izinkinga zezempilo bese uthintana nodokotela wakho ngaphambi kokusebenzisa enye imithi noma wenze ushintsho ohlelweni lwakho.